compound introduction
PF-06426779 is a potent and selective inhibitor of interleukin‑1 receptor associated kinase 4 (IRAK4) , with an IC 50 of 0.3 nM In Vitro PF-06426779 inhibits IRAK4, with an IC 50 of 12.7 nM in the peripheral blood mononuclear cells (PBMCs) assay. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:IRAK4 0.3 nM (IC 50 )
